Michael Joner
Latest contributions
The expanding practice of LAAC today in case examples
01 Oct 2025
Watch this replay with M. Joner, M. Lange and B. Schmidt to understand current indications for left atrial appendage occlusion in clinical practice and so much more!
Emerging indications for TAVI in 2025
22 May 2025 – From EuroPCR 2025
Prepare for emerging TAVI indications anticipated in 2025. This session reviews clinical cases including asymptomatic severe aortic stenosis, moderate aortic stenosis with heart failure, and severe aortic regurgitation. It discusses supporting evidence from clinical trials, evolving transcatheter technologies, and practical treatment approaches for these novel indications.
Is DCB a new valid option for coronary revascularisation?
22 May 2025 – From EuroPCR 2025
This session provides an in-depth evaluation of drug-coated balloons (DCB) as a valid option for coronary revascularisation. Topics include two-year follow-up comparisons between paclitaxel and sirolimus-coated balloons, clinical outcomes after bailout stenting post-DCB angioplasty, meta-analyses contrasting DCB and DES for large native coronary artery disease, and...
How to handle the most clinically relevant challenges in TAVI
21 May 2025 – From EuroPCR 2025
This session explores some of the most clinically complex scenarios encountered in TAVI practice. Three real-world cases address key challenges such as intervention sequencing and transcatheter valve selection in patients with combined coronary artery disease and severe aortic stenosis. The session also examines coronary obstruction risk assessment and...
TAVI for asymptomatic aortic stenosis after EARLY TAVI - TAVI and coronary artery disease after NOTION-3
21 May 2025 – From EuroPCR 2025
Critically assess the clinical implications of the EARLY TAVI and NOTION-3 trials with a focus on asymptomatic aortic stenosis and concomitant coronary artery disease. This session integrates recent evidence into patient-centered care pathways, offering case-based insights for optimizing timing and management strategies in TAVI patients.
The future is now: QFR and RMS to optimise coronary artery disease patient management
20 May 2025 – From EuroPCR 2025
See how next-generation technologies are reshaping coronary artery disease treatment in this EuroPCR 2025 session. Learn how QFR is being used to plan PCI and evaluate results, and discover new insights into RMS technology—offering a potential leap beyond traditional drug-eluting stents. From practical case experience to...
How will EARLY-TAVI and NOTION-3 impact TAVI practice?
21 May 2025 – From EuroPCR 2025
When is the right time to perform TAVI—and how should coexisting coronary artery disease be managed? In this interview, Liesbeth Rosseel, Davide Capodanno, and Michael Joner tackle these two timely questions. They share key takeaways from the EARLY-TAVI trial, which demonstrated reduced rehospitalisation with early intervention...
Degenerated bioprosthesis and Bentall surgery: how to track and position the valve with an angulated ascending aorta conduit?
06 Feb 2025
Complex procedures, such as TAVI in patients with a degenerated bioprosthesis and a Bentall surgery history, demand meticulous planning. This case highlights the importance of computed tomography imaging to minimize procedural risks and explores the snare strategy for navigating anatomical constraints. Learn how this approach, adaptable to...
Author
Author
Author
Electrosurgery and leaflet modification: addressing an unmet need for transcatheter valve interventions
24 Nov 2024 – From PCR London Valves 2024
Electrosurgery and leaflet modification are revolutionizing transcatheter valve interventions, addressing unmet needs for patients who lack conventional treatment options. This video offers a deep dive into the clinical applications of these advanced techniques and equips you with the knowledge to implement them effectively.
You’ll discover:
- How electrosurgical tools,...
Insights from the top late-breaking trials at PCR London Valves 2024
24 Nov 2024 – From PCR London Valves 2024
Looking to stay ahead in transcatheter valve therapies? Don't miss out this video showcasing the most impactful late-breaking trials from PCR London Valves 2024.
Discover pivotal findings, including one-year results comparing two balloon-expandable TAVI valves, outcomes of the TRISCEND II trial for tricuspid regurgitation and groundbreaking insights...
TAVI for today and tomorrow - What matters the most to patients?
28 May 2024
Watch the replay of this webinar with R. Hahn, K. Hayashida, M. Joner and S. Redwood on how to illustrate how TAVI would optimise the full spectrum of lifetime management to all patients and much more!
Artificial intelligence-powered quantification of coronary physiology and vulnerable plaque: opportunities for novel treatment options
15 May 2024 – From EuroPCR 2024
In this session, uncover new data on Murray-law based quantitative flow ratio (muFR) assessment, providing a comprehensive understanding of PCI outcomes from a single angiographic view, explore the innovative application of artificial intelligence in identifying vulnerable plaque and assessing hemodynamic stenosis significance through the analysis of...
TAVI hotline: long-term registry data
15 May 2024 – From EuroPCR 2024
This session presents and discusses long-term registry data on various aspects of transcatheter aortic valve implantation (TAVI). It covers topics such as the surgical versus transcatheter approach in combined coronary and aortic valve disease, long-term outcomes of TAVI versus surgical aortic valve replacement, and registry data...
Elevating quality of heart valve treatment through innovation: SAPIEN 3 Ultra RESILIA and EVOQUE valve systems
14 May 2024 – From EuroPCR 2024
Watch this session to explore how the SAPIEN 3 Ultra RESILIA valve can enhance lifetime management for patients, to find out more about the new treatment options available with the EVOQUE valve, identifying the patient populations that stand to benefit the most, and, additionally, to get...
Bioresorbable scaffolds - new evidence and clinical applications
09 May 2024
Watch this webinar with M. Haude, H. Garcia Garcia, M. Joner and B. Scheller on how to revisit the concept and new technology of BRS and much more!
TAVI: From simple to complex - LIVE case
20 Nov 2023 – From PCR London Valves 2023
This session explores two clinical cases, providing valuable insights into the essential components of a straightforward and efficient TAVI procedure. Find out more about the application of innovative devices to broaden the scope of aortic valve intervention, facilitating their integration into Heart Team discussions and daily...
Is only fixing functional mitral regurgitation in heart failure patients enough?
20 Nov 2023 – From PCR London Valves 2023
This session offers insights into combo therapy involving Carillon for patients with functional mitral regurgitation. It covers details of the EMPOWER trial, a double-blinded, sham-controlled study, and explores the potential benefits of early treatment for patients with functional mitral regurgitation.
Mitral Late-Breaking Trials: CLASP IID, AltaValve transseptal programme, MitraSwiss in men and women, MiCLASP...
19 Nov 2023 – From PCR London Valves 2023
Discover the mitral late-breaking trials which were presented during PCR London Valves 2023:
- One-year outcomes of transcatheter mitral repair from the CLASP IID Registry
- AltaValve transseptal programme update
- Mitral TEER in men and women from MitraSwiss registry: is equality achieved?
- Combined impact of mitral valve gradients and mitral regurgitation reduction...
The catheter-based treatment revolution is just getting started
19 Nov 2023 – From PCR London Valves 2023
Consult this session to stay updated on the latest advancements in transcatheter aortic valve implantations and interventions for tricuspid regurgitation. Gain insights into how recent evidence and innovations are reshaping the treatment landscape for valvular heart disease.
The Top Late-Breaking Trials: TRISCEND II, TRILUMINATE at 3 years, EuroSMR score, CLASP IID, OPERA-TAVI...
19 Nov 2023 – From PCR London Valves 2023
Discover the top late-breaking trials which were presented during PCR London Valves 2023:
- TRISCEND II: A randomised trial of transcatheter tricuspid valve replacement vs medical therapy
- Percutaneous edge-to-edge repair for tricuspid regurgitation: TRILUMINATE trial three-year outcomes
- Transcatheter mitral valve-in-valve vs. redo surgical replacement for degenerated bioprostheses
- Artificial intelligence derived risk...
EuroPCR 2023 Hotlines/Late-Breaking Trials: from (N)STEMI to Chronic Coronary Syndromes (CCS)
19 May 2023 – From EuroPCR 2023
What are the most significant facts in this respect? Get the essentials by listening to the presenters review some clinical hotlines. To cite a few, Selective Intracoronary hypothermia in anterior wall myocardial infarction; real-time catheter-based microvascular obstruction detection in STEMI : results from the MOCCA I...
These papers changed my practice!
18 May 2023 – From EuroPCR 2023
Consult this session if you want to reflect on practical teachings from key papers of leading journals in 2022, to watch real cases translating science into practice, and to meet the editors of EuroIntervention and JACC: Cardiovascular Interventions.
Interventional management of out-of-hospital arrest in 2023
18 May 2023 – From EuroPCR 2023
Consult this session if you want to learn current indications for immediate CAG in out-of-hospital cardiac arrest patients, to learn optimal PCI strategy in patients with out-of-hospital cardiac arrest and multivessel disease, and to learn peri-procedural anticoagulation and anti-aggregation treatment in comatose and intubated out-of-hospital cardiac...
Complex coronary artery disease: can stents and DCB be complementary?
16 May 2023 – From EuroPCR 2023
DES and DCB, can these two technologies be complementary for the treatment of the same patient? What are the advantages and how to proceed? You will know everything by watching this presentation based on concrete cases.
Concomitant aortic valve stenosis and coronary disease in young population with low risk. The younger, the better?
09 Apr 2023
A 73-year-old female with hypertension, obesity and dyslipidemia was admitted to our hospital due to progressive dyspnoea during effort and dizziness. At admission, echocardiography revealed aortic valve stenosis with normal LV-Function...
Author
Author
DCB, when and how to use. A discussion with the experts
24 Jan 2023
Watch the replay of the 1st webinar on DCB. You’ll learn all about 'DCB, when and how to use. A discussion with the experts'
DCB, what you expect to see at follow-up from a “different” approach to PCI
29 Sep 2022
Watch the replay of the 2nd webinar on DCB. You’ll learn all about 'DCB, what you expect to see at follow-up from a “different” approach to PCI'
Innovative approaches to complex peripheral interventions
Discover important innovations regarding complex peripheral interventions: the LimFlow procedure and suture mediated closure devices!
EuroPCR 2022 Hotlines / Late-Breaking Trials in Drug-eluting balloons: U-REDUCE STENT, HYPER, IMPROVED-CTO, and more!
19 May 2022 – From EuroPCR 2022
Find out more about various studies & registries in drug-eluting balloons! A Sirolimus-coated balloon with micro-reservoir technology in coronary lesions, utilisation of DEB guided by post-PCI pressure gradient, DEB in combination with DES in the treatment of diffuse coronary artery disease,DEB for in-stent restenosis and plaque...
